Patents by Inventor Raisa Laptev

Raisa Laptev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100297762
    Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.
    Type: Application
    Filed: August 5, 2010
    Publication date: November 25, 2010
    Applicant: Ariel-University Research and Developmemt Company Ltd.
    Inventors: Michael A. FIRER, Raisa Laptev
  • Patent number: 7772179
    Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.
    Type: Grant
    Filed: April 20, 2006
    Date of Patent: August 10, 2010
    Assignee: Ariel-University Research and Development Company Ltd.
    Inventors: Michael A. Firer, Raisa Laptev
  • Publication number: 20090054306
    Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.
    Type: Application
    Filed: April 20, 2006
    Publication date: February 26, 2009
    Applicant: Ariel-University Research and Development Company Ltd.
    Inventors: Michael A Firer, Raisa Laptev